ArticleCancers2025

Lack of Evidence Supporting a Significant Benefit of Pre-Transplant Consolidation Therapy in AML CR2 Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Meng Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.